<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Merlo DF</submitter><funding>National Institute for Health Research (NIHR)</funding><pagination>193-200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3914866</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>122(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Leukemia incidence has increased in recent decades among European children, suggesting that early-life environmental exposures play an important role in disease development.&lt;h4>Objectives&lt;/h4>We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors. Using cord blood samples from the NewGeneris cohort, we examined associations between a range of biomarkers of carcinogen exposure and hormonally acting factors with micronuclei (MN) frequency as a proxy measure of cancer risk. Associations with gene expression and genotype were also explored.&lt;h4>Methods&lt;/h4>DNA and protein adducts, gene expression profiles, circulating hormonally acting factors, and GWAS (genome-wide association st</pubmed_abstract><journal>Environmental health perspectives</journal><pubmed_title>Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort.</pubmed_title><pmcid>PMC3914866</pmcid><funding_grant_id>RP-PG-0407-10044</funding_grant_id><pubmed_authors>Agramunt S</pubmed_authors><pubmed_authors>Brady NJ</pubmed_authors><pubmed_authors>NewGeneris Consortium</pubmed_authors><pubmed_authors>Chatzi L</pubmed_authors><pubmed_authors>Fthenou E</pubmed_authors><pubmed_authors>Besselink H</pubmed_authors><pubmed_authors>Hemminki K</pubmed_authors><pubmed_authors>Stagi E</pubmed_authors><pubmed_authors>Wright J</pubmed_authors><pubmed_authors>Singh R</pubmed_authors><pubmed_authors>Gallo F</pubmed_authors><pubmed_authors>Vande Loock K</pubmed_authors><pubmed_authors>Godschalk RW</pubmed_authors><pubmed_authors>Kleinjans JC</pubmed_authors><pubmed_authors>Segerback D</pubmed_authors><pubmed_authors>Nomark E</pubmed_authors><pubmed_authors>Schoket B</pubmed_authors><pubmed_authors>Sunyer J</pubmed_authors><pubmed_authors>Tornqvist M</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Nielsen JK</pubmed_authors><pubmed_authors>van Schooten FJ</pubmed_authors><pubmed_authors>Fontana V</pubmed_authors><pubmed_authors>Forsti A</pubmed_authors><pubmed_authors>Mijal R</pubmed_authors><pubmed_authors>Anna L</pubmed_authors><pubmed_authors>Fleming S</pubmed_authors><pubmed_authors>von Stedingk H</pubmed_authors><pubmed_authors>Gmuender H</pubmed_authors><pubmed_authors>Nygaard UC</pubmed_authors><pubmed_authors>van Delft JH</pubmed_authors><pubmed_authors>Lukacs V</pubmed_authors><pubmed_authors>Knudsen LE</pubmed_authors><pubmed_authors>Rydberg P</pubmed_authors><pubmed_authors>Georgiadis P</pubmed_authors><pubmed_authors>Kyrtopoulos SA</pubmed_authors><pubmed_authors>Decordier I</pubmed_authors><pubmed_authors>Botsivali M</pubmed_authors><pubmed_authors>Marcos R</pubmed_authors><pubmed_authors>Hardie LJ</pubmed_authors><pubmed_authors>Kogevinas M</pubmed_authors><pubmed_authors>Kovacs K</pubmed_authors><pubmed_authors>Pedersen M</pubmed_authors><pubmed_authors>Ceppi M</pubmed_authors><pubmed_authors>Lovik M</pubmed_authors><pubmed_authors>Kirsch-Volders M</pubmed_authors><pubmed_authors>Hochstenbach K</pubmed_authors><pubmed_authors>Granum B</pubmed_authors><pubmed_authors>Merlo DF</pubmed_authors><pubmed_authors>Anderson D</pubmed_authors><pubmed_authors>Farmer PB</pubmed_authors><pubmed_authors>van Loveren H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort.</name><description>&lt;h4>Background&lt;/h4>Leukemia incidence has increased in recent decades among European children, suggesting that early-life environmental exposures play an important role in disease development.&lt;h4>Objectives&lt;/h4>We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors. Using cord blood samples from the NewGeneris cohort, we examined associations between a range of biomarkers of carcinogen exposure and hormonally acting factors with micronuclei (MN) frequency as a proxy measure of cancer risk. Associations with gene expression and genotype were also explored.&lt;h4>Methods&lt;/h4>DNA and protein adducts, gene expression profiles, circulating hormonally acting factors, and GWAS (genome-wide association st</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Feb</publication><modification>2026-04-16T09:04:07.684Z</modification><creation>2026-04-07T14:07:24.57Z</creation></dates><accession>S-EPMC3914866</accession><cross_references><pubmed>24252472</pubmed><doi>10.1289/ehp.1206324</doi></cross_references></HashMap>